Veritas Intercontinental
Genetics.The mission of Veritas Int. is to fulfill the promise of the human genome, empowering people to maximize quality and length of life
Veritas Intercontinental has raised €5.0M across 1 funding round from 2 investors, most recently a Series B round in Oct 2020. Based in Madrid, Spain; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€5.0M
€5,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2020-10
latest 2020-10
Funding by year
EUR raised per yearVeritas Intercontinental — funding by year — interactive chart.
Data table
| Veritas Intercontinental — funding by year | |
|---|---|
| 2020 | €5.0M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-16 | Series B | €5.0M | Amadeus Capital Partners,Charme Capital Partners | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData